Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...
As we adjust our print schedule, launch a new website and rely on the U.S. Postal Service for delivery, please know these changes were not made lightly. They were made with our readers in mind — and ...
Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.
aDepartment of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China bDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China ...
Nine years after wowing the audience at the American Society of Clinical Oncology annual meeting with a CAR-T candidate that would become Carvykti—now the world’s most successful cell therapy—Legend ...
Eligibility now includes ages 1–7 years with stage 2 T1D, defined by multiple diabetes autoantibodies plus dysglycemia without clinical, insulin-dependent stage 3 disease. Phase IV PETITE-T1D enrolled ...
Cancer Res (2026) 86 (7_Supplement): 435. Multispecific T cell-engager (TCEs) antibodies have shown great promise as immunotherapeutic molecules. These therapies redirect T cells to recognize and kill ...
KT501 is an IgG-like tri-specific T-cell engager targeting CD3, CD19, and BCMA with high affinity. Credit: angellodeco / Shutterstock.com. Sanofi has signed an exclusive global licence agreement with ...
Cancer Immunol Res (2026) 14 (2_Supplement): C002. Multispecific T cell-engager (TCEs) antibodies have shown great promise as immunotherapeutic molecules. These therapies redirect T cells to recognize ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Primary immune ...
Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This breakthrough may help explain why immunotherapy works for some ...
The gray portion of this schematic represents a nanodisc, where for the first time researchers were able to replicate the native membrane environment (red dots) of a T-cell receptor (cyan). Credit: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results